Active	Status	Sponsor type	Region	Phase	Filter
1 Active 1 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kimozo (temozolomide oral suspension) / Orphelia Pharma
NCT04610736 / 2020-003733-38: TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide	Active, not recruiting	1	49	Europe	Temozolomide Oral Suspension, KIMOZO, Ped-TMZ	Orphelia Pharma, ClinSearch	Pediatric Cancer	01/23	07/23
ORP-011 / Orphelia Pharma
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kimozo (temozolomide oral suspension) / Orphelia Pharma
NCT04610736 / 2020-003733-38: TEMOkids Study : A Phase I Pediatric Study for KIMOZO, Oral Suspension of Temozolomide	Active, not recruiting	1	49	Europe	Temozolomide Oral Suspension, KIMOZO, Ped-TMZ	Orphelia Pharma, ClinSearch	Pediatric Cancer	01/23	07/23
ORP-011 / Orphelia Pharma
No trials found